Detecting Recurrent Breast Cancer: The Role of Liquid Biopsies and Molecular Markers
Ben Park, MD, PhD
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Jacob Sands, MD
Aaron Lisberg, MD
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Alex Spira, MD, PhD, FACP
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
Ritu Salani, MD, MBA
Nicoletta Colombo, MD
Testosterone Revisited: Importance of Monitoring and Impact of Rebound on Quality of Life in Advanced Prostate Cancer
Tanya Dorff, MD
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
Susana Campos, MD, MPH
Recent Advances in ADT: New Insights in Advanced Prostate Cancer Treatment
Rana McKay, MD
Emerging and Practice-Changing Directions in Gynecologic Malignances Involving Combination Therapies With Immune Checkpoint Inhibitors
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Ignacio Duran, MD
Wenxin Xu, MD
Insights From Global Key Opinion Leaders on Optimizing Patient Care in Gynecologic Malignances
Targeted Therapy in the Treatment of Recurrent Platinum-Resistant Ovarian Cancer
Selecting Patients for Novel Breast Cancer Imaging Modalities: The Role of AI
Constance Lehman, MD, PhD
Managing Adverse Effects of Oral vs Injectable ADT in Advanced Prostate Cancer
Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma
Best Practices in Shared Decision-Making: Discussing ADT Regimens in mHSPC With Your Patient
Guideline Updates for ADT: Best Practices for Treating Advanced Prostate Cancer
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.